420 related articles for article (PubMed ID: 32985963)
1. Coronavirus Disease 2019 Vaccine Development: An Overview.
Sumirtanurdin R; Barliana MI
Viral Immunol; 2021 Apr; 34(3):134-144. PubMed ID: 32985963
[TBL] [Abstract][Full Text] [Related]
2. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
Sharma O; Sultan AA; Ding H; Triggle CR
Front Immunol; 2020; 11():585354. PubMed ID: 33163000
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.
Ita K
Arch Med Res; 2021 Jan; 52(1):15-24. PubMed ID: 32950264
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z;
Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794
[TBL] [Abstract][Full Text] [Related]
5. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
[TBL] [Abstract][Full Text] [Related]
6. Messenger RNA vaccines against SARS-CoV-2.
Topol EJ
Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
[TBL] [Abstract][Full Text] [Related]
7. How to redesign COVID vaccines so they protect against variants.
Callaway E; Ledford H
Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
[No Abstract] [Full Text] [Related]
8. Could mixing COVID vaccines boost immune response?
Ledford H
Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
[No Abstract] [Full Text] [Related]
9. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
Liu R; Americo JL; Cotter CA; Earl PL; Erez N; Peng C; Moss B
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688035
[TBL] [Abstract][Full Text] [Related]
10. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
[TBL] [Abstract][Full Text] [Related]
11. DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice.
Szurgot I; Hanke L; Sheward DJ; Vidakovics LP; Murrell B; McInerney GM; Liljeström P
Sci Rep; 2021 Feb; 11(1):3125. PubMed ID: 33542325
[TBL] [Abstract][Full Text] [Related]
12. Novavax offers first evidence that COVID vaccines protect people against variants.
Callaway E; Mallapaty S
Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
[No Abstract] [Full Text] [Related]
13. How 'killer' T cells could boost COVID immunity in face of new variants.
Ledford H
Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217
[No Abstract] [Full Text] [Related]
14. COVID-19 Vaccines: A Primer for Clinicians.
Romero JR; Bernstein HH
Pediatr Ann; 2020 Dec; 49(12):e532-e536. PubMed ID: 33290571
[TBL] [Abstract][Full Text] [Related]
15. Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic.
Liu CH; Huang HY; Tu YF; Lai WY; Wang CL; Sun JR; Chien Y; Lin TW; Lin YY; Chien CS; Huang CH; Chen YM; Huang PI; Wang FD; Yang YP
J Chin Med Assoc; 2021 Jan; 84(1):9-13. PubMed ID: 33186212
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
Pascolo S
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
[TBL] [Abstract][Full Text] [Related]
17. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
18. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
19. The variants of SARS-CoV-2 and the challenges of vaccines.
Han X; Ye Q
J Med Virol; 2022 Apr; 94(4):1366-1372. PubMed ID: 34890492
[TBL] [Abstract][Full Text] [Related]
20. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
